Long-term outcomes with nonmyeloablative HLA-identical related HCT using tacrolimus and MMF for GVHD prophylaxis

Nonmyeloablative allogeneic hematopoietic cell transplantation (HCT) from HLA-identical related donors using cyclosporine (CSP) and mycophenolate mofetil (MMF) for post-grafting immunosuppression is effective therapy for hematologic cancers. However, graft-vs-host-disease (GVHD) remains a major caus...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transplant Cell Ther
Asıl Yazarlar: Oshima, Masumi Ueda, Storer, Barry E., Qiu, Huiying, Chauncey, Thomas, Asch, Julie, Boyer, Michael W., Giaccone, Luisa, Flowers, Mary, Mielcarek, Marco, Storb, Rainer, Maloney, David G, Sandmaier, Brenda M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8035484/
https://ncbi.nlm.nih.gov/pubmed/33830025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2020.10.016
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller